BioAge Labs, Inc. ($BIOA)
Filing Information
| Accession Number | 0001120478-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 13, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
81,000
Total Value
$758,357.69
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 13, 2026 | Exercise/Conversion | 27,000 | $8.39 | $226,530.00 | 49,408 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 13, 2026 | Sale | 8,974 | $18.43 | $165,371.08 | 40,434 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 13, 2026 | Sale | 4,440 | $19.45 | $86,369.54 | 35,994 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 13, 2026 | Sale | 11,663 | $20.54 | $239,548.69 | 24,331 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 13, 2026 | Sale | 1,923 | $21.08 | $40,538.38 | 22,408 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 13, 2026 | Exercise/Conversion | 27,000 | $0.00 | $0.00 | 92,587 | Direct | โ | View Details |